but how accurate is the ecological data that they collect? A new study shows that citizen science data from iNaturalist and eBird can reliably capture known ...

A clinical trial co-led by the Hospital for Special Surgery (HSS) has found that blocking inflammation with the drug ...

Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping ...

Each Unit consisted of (i) one common share in the capital of the Company (each, a “ Common Share ”), and (ii) one Common Share purchase warrant (each, a “ Warrant ”). Each Warrant entitles the holder ...

NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for ...

Scientists have been complaining for years that the way we fund science is flawed. Researchers are too often waiting up to 20 months for grant funding, an eternity in fast-moving fields like ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...

Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those with prior biologic use, positioning it as a potential first-line ...